XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Income $ (5,604,367) $ (7,673,373)
Adjustment to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 1,020,440 1,425,700
Asset Impairments 3,922,110
Amortization of debt issuance costs and accretion of debt discount 94,631 29,974
Non-cash lease expense 5,040 9,194
Equity based compensation expense 4,593,149 277,121
Equity based payments to third parties 719,839 274,477
Gain on sale of business (3,033,554)
Change in unrealized gains (losses) on digital assets, net 8,558
Recognition and change in fair value of warrant liability (156,000)
Earn-out fair value and write-off adjustments 47,761
Change in operating assets and liabilities:    
Accounts receivable 596,335 190,690
Accounts receivable, related parties 3,180 (1,638)
Other receivables (46,306) (5,050)
Prepaid expense and other current assets (112,125) (184,602)
Other non-current assets 1,500 (1,500)
Accounts payables and other accrued liabilities 224,927 189,655
Other payables 59,626 7,600
Net cash used in continuing operating activities (1,469,127) (1,647,881)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (15,901) (19,043)
Purchases of intangibles (26,788) (39,744)
Proceeds from sale of business 4,447,069
Purchases of digital assets (114,960)
Net cash provided (used) from investing activities 4,289,420 (58,787)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Principal repayments of debt (5,913,713) (1,027,177)
Proceeds from short-term financings 192,360 199,948
Principal repayments of short-term financings (144,783) (149,430)
Proceeds from loans payable, related parties 1,142,166
Payments of loans payable, related parties (898,808) (526,119)
Proceeds from common shares issued through an at the market offering 2,021,682 2,824,227
Proceeds from common shares issued through an equity line of credit 350,000  
Private Placement of shares and common warrants 2,136,526  
Net cash (used) provided by continuing financing activities (1,114,570) 1,321,449
Net increase (decrease) in cash and restricted cash 1,705,723 (385,219)
Cash and restricted cash at beginning of year 1,797,694 2,738,911
Cash and restricted cash at end of period $ 3,503,417 $ 2,353,692